Agena Bioscience introduced the Chip prep module to automate sample handling after PCR for the MassARRAY 96-well System.
This enables laboratories to operate the MassARRAY System largely unattended for high-throughput, multiplex genetic analysis.
"Whether you are a lab manager, pathologist, or medical director, automation of the post-PCR workflow reduces labor and helps to improve the quality and consistency of genetic testing. Laboratories can focus resources on the most impactful work," said Peter Dansky, Agena Bioscience’s CEO.
The Chip prep module is designed to minimize hands-on time and reduce the risk of cross contamination associated with manual sample handling. It automates several processing steps, including dispensing and desalting samples onto the SpectroCHIP Array, and subsequently loading these onto the MassARRAY Analyzer.
High throughput laboratories can capitalize on the quick load-and-go process of the Chip prep module.
South Bend Medical Foundation, an early access site, has realized many of the benefits of the MassARRAY System in their clinical laboratory.
"The flexibility to refine complicated testing methods quickly and easily has made the MassARRAY System an integral part of our molecular testing," said Dr. Bobbie Sutton, Pathologist and Director of Molecular Pathology.
"The addition of the Chip prep module simplifies our process and reduces the potential for contamination," added Tammy Ray, Medical Technologist for the laboratory.
The Chip prep module can process eight 96-pad SpectroCHIP Arrays in less than a day and it includes on-board cooling and storage, which allow overnight processing and storage of two additional SpectroCHIP Arrays. The module is an add-on to the MassARRAY Analyzer.
Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY System.
The system is a highly sensitive, cost-effective, mass spectrometry-based platform for high-throughput genetic analysis, and is used globally in diverse fields such as cancer profiling for solid tumors and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research.
The MassARRAY System is intended for research use only, and not intended for use in diagnostic procedures.